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Introduction
Cell line engineering and process intensification efforts
have led to high performing fed-batch cell culture pro-
cesses where cell density can reach >30x106 cells/mL.
These high performance processes also come with new
challenges, in particular developing efficient and scalable
primary recovery processes.
Centrifugation coupled with depth filtration is a standard
approach for clarification of mammalian cell culture broth.
However, with high cell density cultures, it can become
challenging to obtain low turbidity clarified cell culture
fluid (CCCF), and the filtration surface area required for
clarification may become limiting when scaling up.
Objective
We explored novel clarification strategies for cell culture
processes using CHO cell lines producing monoclonal
antibodies, with the goal of removing more impurities
during harvest and increasing the robustness of this pro-
cess step, while opening up possibilities for the reduc-
tion of the filtration surfaces.
Determination of flocculation conditions
All the work described in this abstract was performed
on CHO cell culture processes producing monoclonal
antibodies (mAb). Cell density at harvest was 20-30x106
cells/ml and viability 60-70%. Turbidity of the cell cul-
ture broth at harvest was>2500NTU.
A positively charged flocculation agent, available in
pharmaceutical grade and suitable for GMP manufactur-
ing, was selected. Screening studies were performed at
2L scale in order to identify the most suitable flocculant
concentration and to study the impact of agitation on
the flocculation process. After flocculation, samples
were spun down in a dead end centrifuge and turbidity
of the supernatant was measured as an indicator of floc-
culation efficiency. Selected conditions were: flocculant
concentration 0.0375%; agitation = 100rpm.
Scale-up to 80L
The flocculation conditions selected at 2L scale were
scaled-up to 80L scale, representative of our GMP man-
ufacturing scale. The flocculated broth was processed
through disc-stack centrifugation, depth filtration and
membrane filtration. The impact on product recovery,
product quality, impurity removal and filtration perfor-
mance was assessed.
Impact on filter capacity
Depth filters
Following disc-stack centrifugation, the broth (mAb 1)
was processed through a series of two depth filters. Fil-
tration was performed at constant flow rate. Turbidity
of permeate was used to monitor filtration efficiency.
Results are shown in Figure 1.
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Figure 1 Permeate turbidity according to filtration throughput.
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Membrane filters
The depth filtered material was then processed through
bioburden reduction filters of either 0.2µm or 0.1µm
cut-off. Maximum filtration throughput was used to
determine filtration efficiency. Results are shown in
Table 1.
Impact on product recovery and quality
Impact of flocculation on product recovery and quality
was tested for 3 different mAbs.Titer was measured in
clarified cell culture fluid by protein A HPLC. Acidic
Peak Group (APG) and High Molecular Weight Species
(HMWS) levels were measured on Protein A eluate.
It was shown that the addition of the flocculant did
not impact product recovery and harvest yield for any of
the 3 mAbs tested.
Product quality was also not impacted by the new
clarification process.
Impurity removal
Treated and untreated CCCF (mAb 1) were analyzed in
order to evaluate the impact of flocculation on impurity
removal prior to downstream purification.
It was shown that the introduction of the flocculant
did not affect HCP content, but reduced DNA level
by 90%.
Conclusions
Optimal flocculation agent concentration and agitation
conditions were selected at small scale. Flocculation was
then successfully introduced into a clarification process
representative of GMP manufacturing scale, including
disc-stack centrifugation and depth filtration. Floccula-
tion was shown to have no impact on product recovery
and quality while enabling to increase impurity removal
prior to purification, as well as filtration capacity,
improving robustness and scalability of the process.
Current work is focusing on studying the impact on
chromatography resins and demonstrating clearance of
the flocculation agent during downstream process.
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Table 1. Impact of flocculation on filter capacity and CCCF turbidity
Depth filter capacity [L/m2] 0.2µm filter capacity [L/m2] 0.1µm filter capacity [L/m2] CCCF Turbidity [NTU]
No flocculation 250 1018 16 10
Flocculation >350 6500 569 3
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